C. Schulze, Sertoli cells and Leydig cells in man, Adv Anat Embryol Cell Biol, vol.88, pp.1-104, 1984.

M. P. Hedger and D. M. De-kretser, Leydig cell function and its regulation, Results Probl Cell Differ, vol.28, pp.69-110, 2000.

J. M. Kaufman and A. Vermeulen, The decline of androgen levels in elderly men and its clinical and therapeutic implications, Endocr Rev, vol.26, issue.6, pp.833-76, 2005.

T. Naessen, Higher endogenous estrogen levels in 70-year-old women and men: an endogenous response to counteract developing atherosclerosis? Menopause, vol.19, pp.1322-1330, 2012.

W. Rosner, The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances, Endocr Rev, vol.11, issue.1, pp.80-91, 1990.

W. Rosner, Plasma steroid-binding proteins, Endocrinol Metab Clin North Am, vol.20, issue.4, pp.697-720, 1991.

Z. X. Zhou, The androgen receptor: an overview, Recent Prog Horm Res, vol.49, pp.249-74, 1994.

J. Tostain, D. Rossi, and P. M. Martin,

, Prog Urol, vol.14, issue.5, pp.639-60, 2004.

Z. He, Plasma steroids, body composition, and fat distribution: effects of age, sex, and exercise training, Int J Obes, 2018.

C. Dimopoulou, The complex association between metabolic syndrome and male hypogonadism, Metabolism, 2018.

J. Tostain and D. Rossi,

, Prog Urol, vol.14, issue.5, pp.627-636, 2004.

R. Sodergard, Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature, J Steroid Biochem, vol.16, issue.6, pp.801-811, 1982.

A. Vermeulen, J. M. Kaufman, and V. A. Giagulli, Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males, J Clin Endocrinol Metab, vol.81, issue.5, pp.1821-1827, 1996.

G. Raven, In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion, J Clin Endocrinol Metab, vol.91, issue.9, pp.3324-3332, 2006.

N. Heldring, Estrogen receptors: how do they signal and what are their targets, Physiol Rev, vol.87, issue.3, pp.905-936, 2007.

G. G. Kuiper, Cloning of a novel receptor expressed in rat prostate and ovary, Proc Natl Acad Sci, vol.93, issue.12, pp.5925-5955, 1996.

M. L. Panno, Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells, J Cancer Res Clin Oncol, vol.122, issue.12, pp.745-754, 1996.

D. M. Herrington, Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease

, Engl J Med, vol.346, issue.13, pp.967-74, 2002.

C. Zhao, K. Dahlman-wright, and J. A. Gustafsson, Estrogen receptor beta: an overview and update, Nucl Recept Signal, vol.6, p.3, 2008.

F. J. Hayes, Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback, J Clin Endocrinol Metab, vol.85, issue.9, pp.3027-3062, 2000.

C. J. Bagatell, K. D. Dahl, and W. J. Bremner, The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol, J Androl, vol.15, issue.1, pp.15-21, 1994.

J. S. Finkelstein, Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormonedeficient men, J Clin Endocrinol Metab, vol.73, issue.3, pp.621-629, 1991.

E. P. Smith, Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man, N Engl J Med, vol.331, issue.16, pp.1056-61, 1994.

A. Morishima, Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens, J Clin Endocrinol Metab, vol.80, issue.12, pp.3689-98, 1995.

C. Carani, Effect of testosterone and estradiol in a man with aromatase deficiency, N Engl J Med, vol.337, issue.2, pp.91-96, 1997.

J. D. Veldhuis and A. Iranmanesh, Short-term aromatase-enzyme blockade unmasks impaired feedback adaptations in luteinizing hormone and testosterone secretion in older men, J Clin Endocrinol Metab, vol.90, issue.1, pp.211-219, 2005.

S. Khosla, L. J. Melton, and B. L. Riggs, Clinical review 144: Estrogen and the male skeleton, J Clin Endocrinol Metab, vol.87, issue.4, pp.1443-50, 2002.

L. Gennari, R. Nuti, and J. P. Bilezikian, Aromatase activity and bone homeostasis in men

, J Clin Endocrinol Metab, vol.89, issue.12, pp.5898-907, 2004.

B. L. Riggs, S. Khosla, and L. J. Melton, Sex steroids and the construction and conservation of the adult skeleton, Endocr Rev, vol.3, issue.3, pp.279-302, 2002.

S. Khosla, Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men, J Clin Endocrinol Metab, vol.87, issue.4, pp.1550-1554, 2002.

H. R. Nakhai-pour, Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men, Clin Endocrinol (Oxf), vol.66, issue.3, pp.394-402, 2007.

M. Maggio, Estradiol and inflammatory markers in older men, J Clin Endocrinol Metab, vol.94, issue.2, pp.518-540, 2009.

C. D. Toran-allerand, M. Singh, and G. Setalo, Novel mechanisms of estrogen action in the brain: new players in an old story, Front Neuroendocrinol, vol.20, issue.2, pp.97-121, 1999.

E. Vegeto, P. Ciana, and A. Maggi, Estrogen and inflammation: hormone generous action spreads to the brain, Mol Psychiatry, vol.7, issue.3, pp.236-244, 2002.

E. R. Simpson, Sources of estrogen and their importance, J Steroid Biochem Mol Biol, vol.86, pp.225-255, 2003.

H. A. Feldman, Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study, J Clin Endocrinol Metab, vol.87, issue.2, pp.589-98, 2002.

A. Gray, Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study, J Clin Endocrinol Metab, vol.73, issue.5, pp.1016-1041, 1991.

S. M. Harman, Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging, J Clin Endocrinol Metab, vol.86, issue.2, pp.724-755, 2001.

J. L. Tenover, Testosterone and the aging male, J Androl, vol.18, issue.2, pp.103-109, 1997.

J. M. Davidson, C. A. Camargo, and E. R. Smith, Effects of androgen on sexual behavior in hypogonadal men, J Clin Endocrinol Metab, vol.48, issue.6, pp.955-963, 1979.

A. Morales, Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes, J Urol, vol.157, issue.3, pp.849-54, 1997.

D. M. Kelly and T. H. Jones, Testosterone: a vascular hormone in health and disease, J Endocrinol, vol.217, issue.3, pp.47-71, 2013.

D. M. Kelly and T. H. Jones, Testosterone: a metabolic hormone in health and disease, J Endocrinol, vol.217, issue.3, pp.25-45, 2013.

P. M. Rao, D. M. Kelly, and T. H. Jones, Testosterone and insulin resistance in the metabolic syndrome and T2DM in men, Nat Rev Endocrinol, vol.156, issue.9, pp.479-93, 2013.

F. Saad, Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review, Curr Diabetes Rev, vol.8, issue.2, pp.131-174, 2012.

A. M. Traish, R. Abdou, and K. E. Kypreos, Androgen deficiency and atherosclerosis: The lipid link, Vascul Pharmacol, vol.51, pp.303-316, 2009.

G. Corona, The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction, Int J Androl, vol.32, issue.6, pp.720-728, 2009.

D. E. Laaksonen, Sex hormones, inflammation and the metabolic syndrome: a population-based study, Eur J Endocrinol, vol.149, issue.6, pp.601-609, 2003.

R. Y. Chen, G. A. Wittert, and G. R. Andrews, Relative androgen deficiency in relation to obesity and metabolic status in older men, Diabetes Obes Metab, vol.8, issue.4, pp.429-464, 2006.

M. H. Gannage-yared, Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men, Eur J Endocrinol, vol.155, issue.1, pp.167-76, 2006.

M. Maggio, Association between hormones and metabolic syndrome in older Italian men, J Am Geriatr Soc, vol.54, issue.12, pp.1832-1840, 2006.

S. A. Kaplan, A. G. Meehan, and A. Shah, The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?, J Urol, vol.176, issue.4, pp.1527-1535, 2006.

Y. J. Tang, Serum testosterone level and related metabolic factors in men over 70 years old, J Endocrinol Invest, vol.30, issue.6, pp.451-459, 2007.

V. E. Bianchi and V. Locatelli, Testosterone a key factor in gender related metabolic syndrome, Obes Rev, vol.19, issue.4, pp.557-575, 2018.

J. Elliott, Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis, BMJ Open, vol.7, issue.11, p.15284, 2017.

L. Vandenput and C. Ohlsson, Estrogens as regulators of bone health in men, Nat Rev Endocrinol, vol.5, issue.8, pp.437-480, 2009.

C. Ohlsson and L. Vandenput, The role of estrogens for male bone health, Eur J Endocrinol, vol.160, issue.6, pp.883-892, 2009.

C. Carani,

, J Soc Biol, vol.196, issue.3, pp.245-253, 2002.

M. Maggio, Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons, Arch Intern Med, vol.20, issue.15, pp.1660-1665, 2006.

K. T. Khaw, Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation, vol.116, pp.2694-701, 2007.

G. A. Laughlin, E. Barrett-connor, and J. Bergstrom, Low serum testosterone and mortality in older men, J Clin Endocrinol Metab, vol.93, issue.1, pp.68-75, 2008.

A. Lehtonen, Serum testosterone but not leptin predicts mortality in elderly men, Age Ageing, vol.37, issue.4, pp.461-465, 2008.

A. Tivesten, Low serum testosterone and estradiol predict mortality in elderly men

, J Clin Endocrinol Metab, vol.94, issue.7, pp.2482-2490, 2009.

G. D. Smith, Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study, Circulation, vol.112, issue.3, pp.332-372, 2005.

P. Szulc, B. Claustrat, and P. D. Delmas, Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men--the MINOS study, Clin Endocrinol, vol.71, issue.4, pp.594-602, 2009.

T. Vikan, Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study, Eur J Endocrinol, vol.161, issue.3, pp.435-477, 2009.

A. Menke, Sex steroid hormone concentrations and risk of death in US men, Am J Epidemiol, vol.171, issue.5, pp.583-92, 2010.

A. B. Araujo, Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis, J Clin Endocrinol Metab, vol.96, issue.10, pp.3007-3026, 2011.

R. Haring, Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study, Clin Endocrinol (Oxf), vol.78, issue.4, pp.629-663, 2013.

B. B. Yeap, In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality, J Clin Endocrinol Metab, vol.99, issue.1, pp.9-18, 2014.

S. A. Holmboe, The Association of Reproductive Hormone Levels and All-Cause, Cancer, and Cardiovascular Disease Mortality in Men, J Clin Endocrinol Metab, vol.100, issue.12, pp.4472-80, 2015.

B. Daka, Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus, Atherosclerosis Risk in Communities). Stroke, vol.15, issue.11, pp.2682-2688, 2015.

J. W. Lin, Metabolic syndrome, testosterone, and cardiovascular mortality in men, J Sex Med, vol.8, issue.8, pp.2350-60, 2011.

D. S. Lopez, Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men, Clin Endocrinol (Oxf), vol.88, issue.1, pp.58-65, 2018.

E. L. Ding, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis, JAMA, vol.295, issue.11, pp.1288-99, 2006.

D. E. Laaksonen, Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men, Diabetes Care, vol.27, issue.5, pp.1036-1077, 2004.

W. Barud, Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males, Atherosclerosis, vol.164, issue.2, pp.283-291, 2002.

K. T. Khaw and E. Barrett-connor, Blood pressure and endogenous testosterone in men: an inverse relationship, J Hypertens, vol.6, issue.4, pp.329-361, 1988.

G. A. Laughlin, E. Barrett-connor, and S. May, Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study, Clin Endocrinol (Oxf), vol.65, issue.4, pp.506-519, 2006.

M. Maggio and S. Basaria, Welcoming low testosterone as a cardiovascular risk factor, Int J Impot Res, vol.21, issue.4, pp.261-265, 2009.

T. H. Jones, Testosterone deficiency: a risk factor for cardiovascular disease?, Trends Endocrinol Metab, vol.21, issue.8, pp.496-503, 2010.

Z. Hyde, Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study, J Clin Endocrinol Metab, vol.97, issue.1, pp.179-89, 2012.

R. Haring, Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79, Eur Heart J, vol.31, issue.12, pp.1494-501, 2010.

A. B. Araujo, Sex steroids and all-cause and cause-specific mortality in men, Arch Intern Med, vol.167, issue.12, pp.1252-60, 2007.

T. Goodale, Testosterone and the Heart, Methodist Debakey Cardiovasc J, vol.13, issue.2, pp.68-72, 2017.

B. Hsu, Temporal Changes in Androgens and Estrogens Are Associated With AllCause and Cause-Specific Mortality in Older Men, J Clin Endocrinol Metab, vol.101, issue.5, pp.2201-2211, 2016.

S. B. Fleishman, Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgens, J Clin Oncol, vol.28, issue.34, pp.5054-60, 2010.

J. M. Garcia, Hypogonadism in male patients with cancer. Cancer, vol.106, pp.2583-91, 2006.

M. Maggio, Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti study, J Am Geriatr Soc, vol.57, issue.10, pp.1810-1815, 2009.

L. A. Dossett, High levels of endogenous estrogens are associated with death in the critically injured adult, J Trauma, vol.64, issue.3, pp.580-585, 2008.

V. Scarabin-carre, High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study, J Am Heart Assoc, vol.1, issue.3, p.1388, 2012.

T. Key, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J Natl Cancer Inst, vol.94, issue.8, pp.606-622, 2002.

L. Carcaillon, High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women, Neurology, vol.82, issue.6, pp.504-515, 2014.

Y. X. Chan, Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years, Clin Endocrinol (Oxf), vol.85, issue.4, pp.575-82, 2016.

S. C. Schuit, Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction, JAMA, vol.291, issue.24, pp.2969-77, 2004.

N. C. Onland-moret, The estrogen receptor alpha gene and breast cancer risk (The Netherlands). Cancer Causes Control, vol.16, pp.1195-202, 2005.

A. D. Kjaergaard, Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation, vol.115, pp.861-71, 2007.

V. Scarabin-carre, Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort study, J Clin Endocrinol Metab, vol.99, issue.8, pp.1539-1585, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01148750

N. A. Daniels, Sex hormones and the risk of incident prostate cancer, Urology, vol.76, issue.5, pp.1034-1074, 2010.

Y. X. Chan, Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men, Horm Cancer, vol.8, issue.2, pp.119-126, 2017.

G. Carruba, Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario, J Cell Biochem, vol.102, issue.4, pp.899-911, 2007.

L. A. Brinton, Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk, J Clin Oncol, vol.33, issue.18, pp.2041-50, 2015.

C. S. Group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, issue.6, pp.316-341, 2003.

M. Ronning, Different versions of the anatomical therapeutic chemical classification system and the defined daily dose--are drug utilisation data comparable?, Eur J Clin Pharmacol, vol.56, issue.9, pp.723-730, 2000.

Z. Boleloucky, Aspects of the 10th decennial revision of the international statistical classification of diseases

, Cesk Psychiatr, vol.85, issue.3, pp.183-93, 1989.

K. O. Rove, Role of testosterone in managing advanced prostate cancer, Urology, vol.80, issue.4, pp.754-62, 2012.

J. Sjovall and R. Vihko, Determination of androsterone and dehydroepiandrosterone sulfates in human serum by gas-liquid chromatography, Steroids, vol.6, issue.5, pp.597-604, 1965.

G. E. Abraham, Solid-phase radioimmunoassay of estradiol-17 beta, J Clin Endocrinol Metab, vol.29, issue.6, pp.866-70, 1969.

F. Z. Stanczyk, J. Jurow, and A. W. Hsing, Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies, Cancer Epidemiol Biomarkers Prev, vol.19, issue.4, pp.903-909, 2010.

D. Dufour-rainfray,

, Ann Biol Clin, issue.1, pp.70-78

R. J. Auchus, Steroid assays and endocrinology: best practices for basic scientists, Endocrinology, vol.155, issue.6, pp.2049-51, 2014.

J. M. Bland and D. G. Altman, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, vol.1, issue.8476, pp.307-317, 1986.

V. Soisson, Low plasma testosterone and elevated carotid intima-media thickness: importance of low-grade inflammation in elderly men, Atherosclerosis, vol.223, issue.1, pp.244-253, 2012.

S. Loric, Determination of testosterone in serum not bound by sex-hormone-binding globulin: diagnostic value in hirsute women, Clin Chem, vol.34, issue.9, pp.1826-1835, 1988.

W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, vol.18, issue.6, pp.499-502, 1972.

K. G. Alberti, The metabolic syndrome--a new worldwide definition, Lancet, vol.366, issue.9491, pp.1059-62, 2005.

S. M. Grundy, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, vol.112, pp.2735-52, 2005.

B. Balkau and M. A. Charles, Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR), Diabet Med, vol.16, issue.5, pp.442-445, 1999.

L. Hogben and K. W. Cross, Sampling from a discrete universe. I. Sampling without replacement from a finite universe, Acta Genet Stat Med, vol.3, issue.4, pp.305-347, 1952.

S. Xu, Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health, vol.13, pp.273-280, 2010.

S. R. Cole and M. A. Hernan, Adjusted survival curves with inverse probability weights, Comput Methods Programs Biomed, vol.75, issue.1, pp.45-54, 2004.

P. C. Austin, D. S. Lee, and J. P. Fine, Introduction to the Analysis of Survival Data in the Presence of Competing Risks, Circulation, vol.133, issue.6, pp.601-610, 2016.

B. Lau, S. R. Cole, and S. J. Gange, Competing risk regression models for epidemiologic data, Am J Epidemiol, vol.170, issue.2, pp.244-56, 2009.

E. L. Korn, B. I. Graubard, and D. Midthune, Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale, Am J Epidemiol, vol.145, issue.1, pp.72-80, 1997.

A. C. Thiebaut and J. Benichou, Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study, Stat Med, vol.23, issue.24, pp.3803-3823, 2004.

D. Commenges, Modelling age-specific risk: application to dementia, Stat Med, vol.17, issue.17, pp.1973-88, 1998.

S. David, Partial Residuals for The Proportional Hazards Regression Model, Biometrika, vol.69, issue.1, pp.239-241, 1982.

R. M. Baron and D. A. Kenny, The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations, J Pers Soc Psychol, vol.51, issue.6, pp.1173-82, 1986.

J. M. Robins and S. Greenland, Identifiability and exchangeability for direct and indirect effects, Epidemiology, vol.3, issue.2, pp.143-55, 1992.

J. Pearl, Direct and indirect effects, Proceedings of the Seventeenth Conference on Uncertainty and Artificial Intelligence, pp.411-420, 2001.

T. J. Vanderweele and S. Vansteelandt, Odds ratios for mediation analysis for a dichotomous outcome, Am J Epidemiol, vol.172, issue.12, pp.1339-1387, 2010.

L. Valeri and T. J. Vanderweele, Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros, Psychol Methods, vol.18, issue.2, pp.137-50, 2013.

T. J. Vanderweele, Causal mediation analysis with survival data, Epidemiology, vol.22, issue.4, pp.582-587, 2011.

R. L. Prentice, W. M. Vollmer, and J. D. Kalbfleisch, On the use of case series to identify disease risk factors, Biometrics, vol.40, issue.2, pp.445-58, 1984.

W. W. Piegorsch, C. R. Weinberg, and J. A. Taylor, Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies, Stat Med, vol.13, issue.2, pp.153-62, 1994.

Q. Yang and M. J. Khoury, Evolving methods in genetic epidemiology. III. Geneenvironment interaction in epidemiologic research, Epidemiol Rev, vol.19, issue.1, pp.33-43, 1997.

N. Laouali, Testosterone and All-Cause Mortality in Older Men: The Role of Metabolic Syndrome, J Endocr Soc, vol.2, issue.4, pp.322-335, 2018.

V. Muraleedharan, Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes, Eur J Endocrinol, vol.169, issue.6, pp.725-758, 2013.

M. M. Shores, Testosterone treatment and mortality in men with low testosterone levels, J Clin Endocrinol Metab, vol.97, issue.6, pp.2050-2058, 2012.

E. J. Hamilton, Prevalence and prognosis of a low serum testosterone in men with type 2 diabetes: the Fremantle Diabetes Study Phase II, Clin Endocrinol (Oxf), vol.85, issue.3, pp.444-52, 2016.

A. N. Tint, Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus, Eur J Endocrinol, vol.174, issue.1, pp.59-68, 2016.

V. Soisson, A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study, Maturitas, vol.75, issue.3, pp.282-290, 2013.

K. Sueoka, Higher Endogenous Testosterone Levels Associated with Increased Risk of Coronary Heart Disease in Elderly Men: A Prospective Study, 2010.

S. Basaria, Adverse events associated with testosterone administration, N Engl J Med, vol.363, issue.2, pp.109-131, 2010.

L. Xu, Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials, BMC Med, issue.11, p.108, 2013.

C. Ohlsson, High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men

. Sweden, J Am Coll Cardiol, vol.58, issue.16, pp.1674-81, 2011.

B. B. Yeap, Lower testosterone levels predict incident stroke and transient ischemic attack in older men, J Clin Endocrinol Metab, vol.94, issue.7, pp.2353-2362, 2009.

R. Srinath, Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study, J Clin Endocrinol Metab, vol.100, issue.4, pp.1602-1610, 2015.

J. Svartberg and R. Jorde, Endogenous testosterone levels and smoking in men. The fifth Tromso study, Int J Androl, vol.30, issue.3, pp.137-180, 2007.

T. N. Akbaraly, Metabolic syndrome, its components, and mortality in the elderly, J Clin Endocrinol Metab, vol.95, issue.11, pp.327-359, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00519734

R. Haring, Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality, Andrology, issue.1, pp.17-23, 2013.

J. V. Zhao and C. M. Schooling, Endogenous androgen exposures and ischemic heart disease, a separate sample Mendelian randomization study, Int J Cardiol, vol.222, pp.940-945, 2016.

D. I. Spratt, Reproductive axis suppression in acute illness is related to disease severity, J Clin Endocrinol Metab, vol.76, issue.6, pp.1548-54, 1993.

A. M. Matsumoto, Andropause: clinical implications of the decline in serum testosterone levels with aging in men, J Gerontol A Biol Sci Med Sci, vol.57, issue.2, pp.76-99, 2002.

F. Wang, Relationship between thyroid function and ICU mortality: a prospective observation study, Crit Care, vol.16, issue.1, p.11, 2012.

N. Rodondi, Subclinical hypothyroidism and the risk of coronary heart disease and mortality, JAMA, vol.304, issue.12, pp.1365-74, 2010.

V. Muraleedharan and T. H. Jones, Testosterone and the metabolic syndrome, Ther Adv Endocrinol Metab, vol.1, issue.5, pp.207-230, 2010.

U. Srinivas-shankar, Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study, J Clin Endocrinol Metab, vol.95, issue.2, pp.639-50, 2010.

S. Bhasin, Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle, J Clin Endocrinol Metab, vol.90, issue.2, pp.678-88, 2005.

H. R. Far, G. Agren, and I. Thiblin, Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings, Cardiovasc Pathol, vol.21, issue.4, pp.312-318, 2012.

E. A. Jankowska, Circulating estradiol and mortality in men with systolic chronic heart failure, JAMA, vol.301, issue.18, pp.1892-901, 2009.

J. W. Magnani, Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study, Circ Arrhythm Electrophysiol, vol.7, issue.2, pp.307-319, 2014.

R. D. Abbott, Serum estradiol and risk of stroke in elderly men, Neurology, vol.68, issue.8, pp.563-571, 2007.

, The Coronary Drug Project. Initial findings leading to modifications of its research protocol, JAMA, vol.214, issue.7, pp.1303-1316, 1970.

G. Vandenplas, Endogenous oestradiol and cardiovascular disease in healthy men: a systematic review and meta-analysis of prospective studies, Heart, vol.98, pp.1478-82, 1920.

Y. Pan, Y. Li, and H. Shen, Meta-analysis of the association between polymorphisms of estrogen receptor alpha genes rs9340799 and rs2234693 and Alzheimer's disease: evidence from 23 articles, Am J Alzheimers Dis Other Demen, vol.29, issue.8, pp.704-715, 2014.

Z. Gu, G. Wang, and W. Chen, Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies, Tumour Biol, vol.35, issue.6, pp.5921-5951, 2014.

K. Casazza, G. P. Page, and J. R. Fernandez, The association between the rs2234693 and rs9340799 estrogen receptor alpha gene polymorphisms and risk factors for cardiovascular disease: a review, Biol Res Nurs, vol.12, issue.1, pp.84-97, 2010.

Y. Liu, Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population, Infect Genet Evol, vol.27, pp.69-76, 2014.

D. Goodman-gruen and E. Barrett-connor, Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women, Diabetes Care, vol.23, issue.7, pp.912-920, 2000.

G. Schneider, Increased estrogen production in obese men, J Clin Endocrinol Metab, vol.48, issue.4, pp.633-641, 1979.

M. Maggio, Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study, J Androl, vol.31, issue.2, pp.155-62, 2010.

N. Letellier, Sex-specific association between neighborhood characteristics and dementia: The Three-City cohort, Alzheimers Dement, vol.14, issue.4, pp.473-482, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01635833

M. H. Criqui, Response bias and risk ratios in epidemiologic studies, Am J Epidemiol, vol.109, issue.4, pp.394-403, 1979.

G. D. Batty, Generalizability of occupational cohort study findings, Epidemiology, vol.25, issue.6, pp.932-935, 2014.

D. J. Brambilla, The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men, J Clin Endocrinol Metab, vol.94, issue.3, pp.907-920, 2009.

M. Muller, Endogenous sex hormones and cardiovascular disease in men, J Clin Endocrinol Metab, vol.88, issue.11, pp.5076-86, 2003.

J. Taieb, Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children, Clin Chem, vol.49, issue.8, pp.1381-95, 2003.

S. Chung, Disruption of the melanin-concentrating hormone receptor 1 (MCH1R) affects thyroid function, Endocrinology, vol.153, issue.12, pp.6145-54, 2012.

P. Toniolo and A. Lukanova, The challenge of measuring circulating estradiol at low concentrations, Breast Cancer Res, vol.7, issue.2, pp.45-52, 2005.

K. Krithivas, Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men, J Endocrinol, vol.162, issue.1, pp.137-179, 1999.

A. Scientifique-e1, Premier article : TESTOSTERONE AND ALL-CAUSE MORTALITY IN OLDER MEN: THE ROLE OF METABOLIC SYNDROME

, Deuxième article : ESTRADIOL LEVEL, ESTROGEN RECEPTORS, AND MORTALITY IN ELDERLY MEN: THE THREE-CITY COHORT STUDY, vol.2

, Crude analyses. ¥: Inversely probability weighted Cox

, Model 1: adjusted for age and center; model 2: model 1 + personal history of coronary disease and stroke, daily alcohol consumption, hypertension, diabetes, and sex hormone-binding globulin; model 3: model 2 + smoking, Notes: ¥ : Hazard ratios (HR) and 95% confidence intervals (CI) computed using inverse probability weighted Cox models